Showing results (21-30 of 170) with videos related to
Sort By:
Pageof 17
Bulletin Du Cancer|February 5, 1999
[Irinotecan: various administration schedules, study of drug combinations, phase I experience]V Boige, E Raymond, J P ArmandHematology/Oncology Clinics of North America|August 1, 1991
Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implicationsE Cvitkovic, M Bachouchi, J P ArmandCancer Research|September 1, 1984
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II)J P Macquet, S Cros, J P ArmandEuropean Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trialsJ P Armand, L Seymour, T R EvansPathologie-Biologie|June 7, 2006
[Targeting angiogenesis in oncology]J Fayette, J-C Soria, J-P ArmandBulletin Du Cancer|December 1, 1994
[Cardiotoxicity of 5-fluorouracil: a question of formulation]L Lemaire, M Arellano, M C Malet-Martino, et al.Bulletin Du Cancer|January 1, 1990
[Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines]M C Malet-Martino, R Martino, J P ArmandAnnals of the New York Academy of Sciences|December 13, 1996
CPT-11. The European experienceJ P Armand, C Terret, C Couteau, et al.British Journal of Cancer|July 1, 1992
Cardiotoxicity of commercial 5-fluorouracil vials stems from the alkaline hydrolysis of this drugL Lemaire, M C Malet-Martino, M de Forni, et al.Pageof 17